文献速递母胎医学生殖医学

游离DNA用于胎儿非整倍体检测

Cell-free DNA for the detection of fetal aneuploidy.
PubMed 文献 · Fertil Steril · 2018-01-01

游离DNA筛查胎儿非整倍体已有二十余年历史,美国产科提供者临床应用超过5年,对唐氏综合征及其他常见非整倍体检测效果优良。但DNA来源和筛查试验性质可能导致需要专家咨询的复杂情况,不孕症专家需理解该筛查的优势与局限,尤其考虑到胚胎扩展遗传学检测。

要点

  • 游离DNA对胎儿唐氏综合征及其他常见非整倍体检测效果优良
  • 该筛查的DNA来源和试验性质可引发需专家咨询的胎儿与母体健康、检测解读及管理问题
  • 不孕症专家需理解该筛查的优势与局限,尤其结合胚胎扩展遗传学检测

核心结论

  • 游离DNA筛查对胎儿唐氏综合征和其他常见非整倍体检测效果优良,但可能引发需专家咨询的复杂问题,不孕症专家应理解其优势与局限。

主要发现

  • 游离DNA筛查胎儿非整倍体已有二十余年描述,美国产科提供者临床应用超过5年。

临床怎么用

  • 不孕症专家需理解该筛查试验的优势与局限,尤其考虑到胚胎扩展遗传学检测。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Screening for fetal aneuploidy via cell-free DNA was described more than two decades ago and has been used clinically by obstetric providers in the United States for more than 5 years. Cell-free DNA affords excellent detection of fetal Down syndrome and other common aneuploidies and thus is sought by patients and providers. However, owing to the source of the DNA and the nature of the screening test, scenarios may arise that require expert counseling about complex issues regarding fetal and maternal health, test interpretation, and management. It is essential that infertility specialists understand the specific issues related to the strengths and limitations of this screening test, especially in light of expanded genetic testing of embryos.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Goldwaser T, Klugman S. Cell-free DNA for the detection of fetal aneuploidy. Fertil Steril. 2018. PMID: 29447662. doi:10.1016/j.fertnstert.2017.12.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。